chugai

You are now moving to an external website.
Disclaimer
This link will lead you to leave the website of Chugai Pharma Taiwan; the content of the linked website you choose (links, changes, or updates in this website) is no longer the responsibility of Chugai Pharma Taiwan. Chugai Pharma Taiwan does not take any legal responsibility for the information transmitted by this linked website.This link is for your convenience only, and any link does not mean that Chugai Pharma Taiwan endorses or approves its website content.

Access the link
Hematology
PIASKY for Injection
衛部罕菌疫輸字第000055號
Previous Page Home Products Hematology
Previous PageHome Products
Product Introduction

Indication：

test

PIASKY for Injection 340mg/2mL

test

PIASKY for Injection 340mg/2mL

PIASKY is a complement C5 inhibitor indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg.

Mechanism of Action：

Crovalimab-akkz is a monoclonal antibody that specifically binds with high affinity to the complement protein C5, inhibiting its cleavage into C5a and C5b, preventing the formation of the membrane attack complex (MAC). Crovalimab-akkz inhibits terminal complement-mediated intravascular hemolysis in patients with PNH.

Product Specification
Product Name
PIASKY for Injection 340mg/2mL
Related Links
PIASKY for Injection 340mg/2mL License